CALYXT INC (CLXT) Stock Price, Forecast & Analysis
USA - NASDAQ:CLXT - US13173L2060 - Common Stock
CLXT Key Statistics, Chart & Performance
The current stock price of CLXT is 6.3 USD. In the past month the price increased by 99.37%. In the past year, price increased by 107.37%.
CLXT Latest News, Press Relases and Analysis
CLXT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 23.14 | 386.36B | ||
| AMGN | AMGEN INC | 14.8 | 174.25B | ||
| GILD | GILEAD SCIENCES INC | 14.43 | 146.60B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.26 | 107.99B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.55 | 69.40B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 866.08 | 57.90B | ||
| INSM | INSMED INC | N/A | 40.57B | ||
| NTRA | NATERA INC | N/A | 28.36B | ||
| BIIB | BIOGEN INC | 9.33 | 22.91B | ||
| INCY | INCYTE CORP | 16.51 | 20.70B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.2 | 20.53B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 35.89 | 14.88B |
Related stock screener links
About CLXT
Company Profile
Calyxt Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Roseville, Minnesota and currently employs 25 full-time employees. The company went IPO on 2017-07-20. Calyxt, Inc. is a plant-based synthetic biology company. The firm is focused on research and development, including gene editing, plant breeding, and trait development. The company specializes in engineering plant metabolisms. The firm leverages its PlantSpring technology platform to engineer plant metabolism to produce sustainable materials and products for use in helping customers meet. The firm operates through the development and commercialization of products derived from plant cells. Its platform provides plant-based synthetic biology solutions to customers across multiple industries. The firm has engineered plant metabolism into products including soybeans with improved fatty-acid profiles and alfalfa able to be better digested by livestock. Its product pipeline includes hemp, winter oats, and high saturated fat soybeans. Hemp serves a range of varieties of materials science needs, including strengthening plastics and reducing petroleum-based content.
Company Info
CALYXT INC
2800 Mount Ridge Rd
Roseville MINNESOTA 55113 US
CEO: Yves Ribeill
Employees: 25
Phone: 16516832807.0
CALYXT INC / CLXT FAQ
Can you describe the business of CALYXT INC?
Calyxt Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Roseville, Minnesota and currently employs 25 full-time employees. The company went IPO on 2017-07-20. Calyxt, Inc. is a plant-based synthetic biology company. The firm is focused on research and development, including gene editing, plant breeding, and trait development. The company specializes in engineering plant metabolisms. The firm leverages its PlantSpring technology platform to engineer plant metabolism to produce sustainable materials and products for use in helping customers meet. The firm operates through the development and commercialization of products derived from plant cells. Its platform provides plant-based synthetic biology solutions to customers across multiple industries. The firm has engineered plant metabolism into products including soybeans with improved fatty-acid profiles and alfalfa able to be better digested by livestock. Its product pipeline includes hemp, winter oats, and high saturated fat soybeans. Hemp serves a range of varieties of materials science needs, including strengthening plastics and reducing petroleum-based content.
What is the current price of CLXT stock?
The current stock price of CLXT is 6.3 USD. The price increased by 5.53% in the last trading session.
Does CALYXT INC pay dividends?
CLXT does not pay a dividend.
What is the ChartMill rating of CALYXT INC stock?
CLXT has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for CLXT stock?
CALYXT INC (CLXT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.04).
What is the expected growth for CLXT stock?
The Revenue of CALYXT INC (CLXT) is expected to grow by 38.59% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
CLXT Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CLXT. When comparing the yearly performance of all stocks, CLXT is one of the better performing stocks in the market, outperforming 97.73% of all stocks.
CLXT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CLXT. CLXT may be in some trouble as it scores bad on both profitability and health.
CLXT Financial Highlights
Over the last trailing twelve months CLXT reported a non-GAAP Earnings per Share(EPS) of -3.04. The EPS decreased by -289.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
CLXT Forecast & Estimates
8 analysts have analysed CLXT and the average price target is 36.98 USD. This implies a price increase of 486.9% is expected in the next year compared to the current price of 6.3.
For the next year, analysts expect an EPS growth of 82.92% and a revenue growth 38.59% for CLXT